Oligogen, Inc. Alternatives & Competitors

12 companies similar to Oligogen, Inc. — Oligogen, Inc. is a biotech startup developing stem cell therapies for central n...

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

Cell BioEngines, Inc

‘Off-the-Shelf’ Curative Cell Therapies

3 Pre-Seed $1.38M

New York, United States

Biotechnology Health and Wellness

Relmada Therapeutics, Inc

Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the tre...

32 Post-IPO Equity

Coral Gables, United Stat...

Biotechnology Pharmaceutical

Caribou Biosciences

Clinical-stage biopharmaceutical company developing transformative therapies to treat deva...

128 IPO $588.55M

Berkeley, United States

Biotechnology Health Care +1

Track all Oligogen, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

TreeFrog Therapeutics

Cell Therapy for All

177 Debt Financing $104.17M

Pessac, France

Biopharma Biotechnology +1

Compare

RHEACELL GmbH & Co. KG

Innovative Stem Cell Therapies Experts from Heidelberg, Germany

Heidelberg, Germany

Biotechnology Pharmaceutical

Montara Therapeutics, Inc.

At Montara, we’re developing safer, more efficacious therapies to improve the lives of pat...

24 Seed $29.00M

San Francisco, United Sta...

Biopharma Biotechnology +1

Hemera Pharma

A University of Verona and Milan spin-offs specialized in regenerative medicine for neurol...

Verona, Italy

Biotechnology Health and Wellness +1

AGY Therapeutics

Pioneering breakthrough treatments for central nervous system diseases through innovative...

Series C $22.00M

Biopharma Biotechnology +1

Rakuten Medical

Rakuten Medical, Inc. is a global biotechnology company in pursuit of conquering cancer.

120 Series E $737.59M

San Diego, United States

Biotechnology Health Care +1

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

Longeveron Inc

Cell-Based Therapies

29 Post-IPO Equity $34.01M

Miami, United States

Biotechnology Health and Wellness +1

About Oligogen, Inc.

Oligogen, Inc. is a Japanese biotech startup founded in 2015 with a focus on developing stem cell therapies for central nervous system (CNS) diseases. The company's patented neural stem cell technology “OligoGenie” has garnered global recognition, with patents in over 29 countries.

Taxonomy

Biotech Startup, Stem Cell Therapies, Central Nervous System Diseases, Neural Stem Cell Technologies, OligoGenie, Patented Technology, Pre-clinical Phase, Drug Development, Bio-venture, Spinal Cord Injury

Frequently Asked Questions

Companies similar to Oligogen, Inc. include Reviva Pharmaceuticals, Cell BioEngines, Inc, Relmada Therapeutics, Inc, Caribou Biosciences, TreeFrog Therapeutics. They work in Biotechnology and Health and Wellness and share Oligogen, Inc.'s focus on central nervous system diseases, drug development and stem cell therapies.

Bounce Watch lists 12 companies that share Oligogen, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Oligogen, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Oligogen, Inc. Profile Cell BioEngines, Inc Alternatives Caribou Biosciences Alternatives TreeFrog Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Oligogen, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.